MedPath

Effects Of Peplau’s Theory relationship in thalassemia

Not Applicable
Conditions
Thalassemia.
Beta thalassemia
D56.1
Registration Number
IRCT20141125020082N3
Lead Sponsor
Iranshahr University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

The patient must be able to read and write.
not suffer from mental illnesses and cognitive disorders.
No vision impairment
Balochi or Farsi language
Absence of acute illness
No hearing impairment

Exclusion Criteria

use of barbiturates and anti-anxiety drugs
having diabetes
Undergoing splenectomy surgery before the study
Undergoing bone marrow transplant surgery before the study
having heart failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety score based on DASS-21 questionnaire. Timepoint: The beginning of the intervention, two weeks and one month after the intervention. Method of measurement: DASS-21 questionnaire.;Depression score based on DASS-21 questionnaire. Timepoint: The beginning of the intervention, two weeks and one month after the intervention. Method of measurement: DASS-21 questionnaire.;Quality of life score based on sf-36 questionnaire. Timepoint: The beginning of the intervention, two weeks and one month after the intervention. Method of measurement: sf-36 questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath